NovoCure20Limited (NVCR) - NASDAQGS
Revenue / EPS Summary *
Fiscal Quarter
2017
(Fiscal Year)
2016
(Fiscal Year)
2015
(Fiscal Year)
March
Revenue
$34,880(t)
$13,053(t)
EPS
-0.21 (3/31/2017)
-0.42 (3/31/2016)
Dividends
N/A
N/A
June
Revenue
$38,376(t)
$17,919(t)
EPS
-0.24 (6/30/2017)
-0.48 (6/30/2016)
Dividends
N/A
N/A
September
Revenue
$50,109(t)
$21,674(t)
$8,953(t)
EPS
-0.12 (9/30/2017)
-0.39 (9/30/2016)
-2.09 (9/30/2015)
Dividends
N/A
N/A
N/A
December (FYE)
Revenue
$53,661(t)
$30,242(t)
$12,383(t)
EPS
-0.13 (12/31/2017)
-0.25 (12/31/2016)
2.54 (12/31/2015)
Dividends
N/A
N/A
N/A
Totals
Revenue
$177,026(t)
$82,888(t)
$21,336(t)
EPS
-0.7
-1.54
0.45
Dividends
N/A
N/A
N/A
Next 3 Years
Previous 3 Years
©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.